Sonic Healthcare Ltd
ASX: SHL · Health Care · Diagnostics & Research
- Market cap
- A$10.5B
- P/E (trailing)
- 20.5
- EPS (FY25)
- $1.07
- Dividend / share
- $1.18
- 52-week range
- –
- Intrinsic value
- A$19.79
Share price
ASX: SHL · AUD
Valuation
Full valuation analysis →Fair-value estimate per share, updated 2 Aug 2026
A$19.79 The median of our 3 model estimates
10.5% above fair value Against the A$21.86 price.
- Discounted cash flow
- A$25.02
- EPS growth model
- A$15.56
- P/E multiple
- A$19.79
Revenue
As reported · financial years
Earnings per share
Diluted · as reported
Profit margins
Gross, operating and net margin by financial year
Mediocre Net margin of 5.3% in FY25: thin margins leave little room for shocks.
Shares outstanding
Diluted · falling means buybacks, rising means dilution
Stable +0.9% year-on-year, +1.8% a year over 10 years: share count has been stable over the long run.
Working-capital days
Days of revenue sitting in receivables (DSO) and days of cost sitting in inventory (DIO)
Slowing collections DSO of 57 days vs a 49-day norm: customers are taking longer to pay than the historical norm.
Financial health
Latest financial year (FY25)
- Return on equity
- 6.1%
- Weak
- Current ratio
- 1.17
- Adequate
- Debt to equity
- 0.61
- Moderate
- Interest coverage
- 5.2×
- Adequate
Verdicts are graded against what's normal for the sector (Health Care), not a one-size-fits-all bar. Hover a tile for the reasoning.
Dividends per share
Full dividend history →Per financial year, as reported in the accounts
Cash-covered payout 111% of FY25 earnings paid out: the dividend exceeds accounting earnings but is covered by free cash flow, since non-cash charges hold reported profit below the cash the business generates.
Free cash flow
Cash from operations minus capital spending: what the DCF model projects from
Excellent 187% of FY25 net profit became free cash: free cash flow exceeds reported profit.
Net debt
Borrowings and leases minus cash: the line shows how many years of operating profit (EBIT) would clear it
High leverage Net debt of $4.5B is 4.8× FY25 operating profit: it would take years of operating profit to clear the net debt.
Five-year snapshot
Figures as reported in the company's filings
| Metric | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $8.8B | $9.3B | $8.2B | $9.0B | $9.6B |
| Net profit | $1.3B | $1.5B | $685.0M | $511.1M | $513.6M |
| EPS (diluted) | $2.73 | $3.03 | $1.45 | $1.07 | $1.07 |
| Dividend / share | $0.89 | $0.98 | $1.04 | $1.17 | $1.18 |
| Net margin | 15.0% | 15.6% | 8.4% | 5.7% | 5.3% |
Common questions about SHL
Is SHL undervalued right now? +–
The median of our 3 model estimates puts Sonic Healthcare Ltd's fair value at A$19.79 per share against a price of A$21.86, 10.5% above the estimate as at 2 Aug 2026. Model estimates are a starting point, not advice. See the full valuation breakdown.
Does SHL pay a dividend? +–
Sonic Healthcare Ltd paid $1.18 per share in its most recent financial year with a recorded dividend. The dividend history chart above shows the full payout record.
How fast is SHL growing? +–
Revenue has compounded at 7.1% a year over the last five financial years, and 8.7% a year over ten.
What is SHL's P/E ratio? +–
Sonic Healthcare Ltd trades on a trailing price-to-earnings ratio of 20.5, based on diluted earnings of $1.07 per share in FY25.
Compare SHL with peers
Data is general information only, not financial advice. Figures are as reported in company filings (some ASX companies report in USD); share prices are AUD.